1. Eberstadt N. The future of AIDS. Foreign Affairs Nov/Dec 2002 Vol. 81.
2. The next wave of HIV/AIDS: Nigeria, Ethiopia, Russia, India, and China. National Intelligence Council USA; 2002. ICA 2002-04 D, available from: http://www.odci.gov/nic
3. Sharma DC. US charity donation for HIV/AIDS in India sparks government row. Lancet 2002;360:1574.
4. 2004 Report on the global HIV/AIDS epidemic: 4th global report. Geneva: Joint United Nations Programme on HIV/AIDS; 2004.
5. Grassly NC, Lowndes CM, Rhodes T, Judd A, Renton A, Garnett GP. Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India. International Journal of Drug Policy 2003;14:25-43.
6. Auvert B, Buve A, Ferry B, Carael M, Morison L, Lagarde E, et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 2001;15:S15-30.
7. Drain PK, Smith JS, Hughes JP, Halperin DT, Holmes KK. Correlates of national HIV seroprevalence: an ecologic analysis of 122 developing countries. Journal of Acquired Immune Deficiency Syndromes 2004;35:407-20.
8. Bloom SS, Urassa M, Isingo R, Ng'weshemi JZL, Boerma JT. Community effects on the risk of HIV infection in rural Tanzania. Sexually Transmitted Infections 2002;78:261-6.
9. UNAIDS Reference Group on Estimates, Modelling and Projections. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 2002;16:W1-16.
10. Anderson RM, May RM, Boily MC, Garnett GP. Rowley JT. The spread of HIV-1 in Africa – sexual contact patterns and the predicted demographic impact of AIDS. Nature 1991;352:581-9.
11. Walker N, UNAIDS, quoted in: Washington Post 1 October 2002.
12. Pisani E. Estimating the size of populations at risk for HIV: issues and methods. Arlington (VA): UNAIDS/IMPACT/Family Health International; 2002.
13. Walker N, Stover J, Stanecki KA, Zaniewski E, Grassly NC, Calleja-Garcia J-M, et al. The workbook approach to making estimates and projecting future scenarios of HIV/AIDS in countries with low level and concentrated epidemics. Sexually Transmitted Infections 2004; 80 Suppl 1:i10-i13.
14. Mills S. Back to behaviour: prevention priorities in countries with low HIV prevalence. AIDS 2000;14 Suppl 3:S267-73.
15. Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD, et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 2002;360:73-7.
16. Amon J, Brown T, Hogle J, MacNeil J, Magnani R, Mills S, et al. Surveillance surveys: BSS guidelines for repeated behavioral surveys in populations at risk of HIV. Arlington (VA): Family Health International; 2000.
17. Dorabjee J, Samson L. A multi-centre rapid assessment of injecting drug use in India. International Journal of Drug Policy 2000;11:99-112.
18. HIV estimates in India. Delhi: National AIDS Control Organisation (NACO); 2004 (available from: http://naco.nic.in).
19. Hunter PR, Fewtrell L. Acceptable risk. In: Fewtrell L, Bartram J, editors. Water quality – guidelines, standards and health: assessment of risk and risk management for water-related infectious disease. Geneva: World Health Organization; 2000.
20. Shkolnikov V, McKee M, Leon DA. Changes in life expectancy in Russia in the mid-1990s. Lancet 2001;257:917-21.
21. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe. Mid-year report 2002. Saint-Maurice: Institut de Veille Sanitaire; 2002.
22. Pisani EP, Garnett GP, Brown T, Stover J, Grassly NC, Hankins C, et al. Back to basics in HIV prevention: a focus on exposure. BMJ 2003;326:1384-7.
23. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002;359:1635-42.
24. Merson MH, Dayton JM, O'Reilly K. Effectiveness of HIV prevention interventions in developing countries. AIDS 2000;14 Suppl 2:S68-84.
25. Anderson RM, May RM. Infectious diseases of humans: dyamics and control. Oxford: Oxford University Press; 1991.
26. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002;324:1570-6.
27. Anderson RM, Medley GF, May RM, Johnson AM. A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV) the causative agent of AIDS. IMA Journal of Mathematics Applied in Medicine and Biology 1986;3:229-63.
28. Blower SM, Hartel D, Dowlatabadi H, Anderson RM, May RM. Drugs, sex and HIV: a mathematical model for New York City. Philosophical Transactions of the Royal Society of London, Series B 1991;321:171-87.
29. Grassly NC, Garnett GP, Schwartlander B, Gregson S, Anderson RM. The effectiveness of HIV prevention and the epidemiological context. Bulletin of the World Health Organization 2001;79:1121-32.
30. Garnett GP, Anderson RM. Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. Journal of Acquired Immune Deficiency Syndromes 1995;9:500-13.
31. Stoneburner RL, Low-Beer D. Population-level HIV decline and behavioral risk avoidance in Uganda. Science 2004;304:714-8.
32. The world health report 2002 – Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
33. National estimates of adult HIV infection, Indonesia 2002. Jakarta: Ministry of Health of the Republic of Indonesia, Directorate General of Communicable Disease Control and Environmental Health; 2003. p. 53.